These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11077647)

  • 41. Long-acting contraceptives in adolescents.
    Tolaymat LL; Kaunitz AM
    Curr Opin Obstet Gynecol; 2007 Oct; 19(5):453-60. PubMed ID: 17885461
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Use of a parenteral estroprogestin as an inhibitor of ovulation in a single monthly administration].
    Cappello F
    Minerva Ginecol; 1975 Dec; 27(12):964-8. PubMed ID: 778680
    [No Abstract]   [Full Text] [Related]  

  • 43. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H; Stevenson J
    Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Merits of DMPA relative to other reversible contraceptive methods.
    Nelson A
    J Reprod Med; 2002 Sep; 47(9 Suppl):781-4. PubMed ID: 12380406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.
    Kaunitz AM; Darney PD; Ross D; Wolter KD; Speroff L
    Contraception; 2009 Jul; 80(1):7-17. PubMed ID: 19501210
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Depot medroxyprogesterone acetate (DMPA) injectable contraception--safe, effective but neglected method of family planning in Poland].
    Lech MM
    Wiad Lek; 2003; 56(7-8):362-8. PubMed ID: 14969166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Advances in hormonal contraception.
    Gupta N
    Adolesc Med Clin; 2006 Oct; 17(3):653-71; abstract xi. PubMed ID: 17030284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evra contraceptive patch: risks of thromboembolism.
    Prescrire Int; 2007 Jun; 16(89):113-4. PubMed ID: 17590909
    [No Abstract]   [Full Text] [Related]  

  • 49. Self-administration of injectable contraceptives.
    Prabhakaran S
    Contraception; 2008 May; 77(5):315-7. PubMed ID: 18402845
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaginal discharge: a perceived side effect and minor reason for discontinuation in hormonal injectable users in South Africa.
    Beksinska ME; Rees HV
    Afr J Reprod Health; 2001 Dec; 5(3):84-8. PubMed ID: 12471932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progesterone and medroxyprogesterone acetate effects on central and peripheral allopregnanolone and beta-endorphin levels.
    Bernardi F; Pluchino N; Pieri M; Begliuomini S; Lenzi E; Puccetti S; Casarosa E; Luisi M; Genazzani AR
    Neuroendocrinology; 2006; 83(5-6):348-59. PubMed ID: 16931878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [An introductory clinical trial of three-monthly injectable contraceptive-depot medroxyprogesterone acetate].
    Shao Q; Jiang H; Fu W
    Zhonghua Fu Chan Ke Za Zhi; 1999 Jan; 34(1):36-9. PubMed ID: 11263172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Depot-medroxyprogesterone acetate: an update.
    Bakry S; Merhi ZO; Scalise TJ; Mahmoud MS; Fadiel A; Naftolin F
    Arch Gynecol Obstet; 2008 Jul; 278(1):1-12. PubMed ID: 18470526
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dose-dependent changes of the ratio of apoptosis to proliferation by norethisterone and medroxyprogesterone acetate in human breast epithelial cells.
    Seeger H; Rakov V; Mueck AO
    Horm Metab Res; 2005 Aug; 37(8):468-73. PubMed ID: 16138258
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Progestogens in gynaecological practice.
    Bharucha MR
    Indian Med Trib; 1995 Aug; 3(13):6-7. PubMed ID: 12179192
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Experiences with a 3-monthly injections of medroxyprogesterone acetate (MPA) as a contraceptive agent].
    Linthorst G; Wibaut EP; de Jongh RE
    Ned Tijdschr Geneeskd; 1972 Sep; 116(38):1694-8. PubMed ID: 5069858
    [No Abstract]   [Full Text] [Related]  

  • 57. Re: "Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study".
    Shapiro S
    Am J Epidemiol; 2008 Nov; 168(10):1213; author reply 1213-4. PubMed ID: 18922997
    [No Abstract]   [Full Text] [Related]  

  • 58. Emancipation in decision-making in women's health care.
    Wittmann-Price RA
    J Adv Nurs; 2004 Aug; 47(4):437-45. PubMed ID: 15271163
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.
    Wood CE; Register TC; Lees CJ; Chen H; Kimrey S; Cline JM
    Breast Cancer Res Treat; 2007 Jan; 101(2):125-34. PubMed ID: 16841178
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lunelle: a new contraceptive alternative.
    Wysocki S
    Nurse Pract; 2001 Jun; 26(6):55-9. PubMed ID: 11416940
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.